Replies to post #358876 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

What? Sometimes UCLA calls it DCVax-L. Other times, it calls it DC Vaccine or DCVax. Here is the link (courtesy of moderation23) that directly refers to DCVax-L in the UCLA Combo Project I Trial:
https://cancer.ucla.edu/research/ucla-brain-spore/research-projects

Finally, in Aim 3, we will develop and validate predictive tumor, immunological and imaging biomarkers of response in recurrent glioblastoma patients enrolled in a Phase II clinical trial of DCVax-L +/- PD-1 blockade.

Also, thanks to VuBru, another DCVax-L reference:

You can also go to the NIH Reporter website, search for Linda Liau, and see for yourself.
https://projectreporter.nih.gov/reporter.cfm